Laboratorios Richmond SACIF (RICH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$202.02 Million ≈ $146.18K USD) by net assets (AR$72.73 Billion ≈ $52.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RICH stock market capitalisation for the company's overall valuation and market capitalisation.

Laboratorios Richmond SACIF - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laboratorios Richmond SACIF Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Richmond SACIF ranked by their cash flow conversion efficiency. Explore Laboratorios Richmond SACIF earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Tamawood Ltd
AU:TWD
0.075x
Cps Technologies
NASDAQ:CPSH
-66.268x
Viatron Technologies Inc
KQ:141000
0.050x
Manaksia Steels Limited
NSE:MANAKSTEEL
0.090x
Maxiparts Ltd
AU:MXI
0.065x
Renergen Ltd.
JSE:REN
-0.171x
Tycoons Group Enterprise Co Ltd
TW:2022
-0.033x
NICE Total Cash Management Co. Ltd
KQ:063570
0.149x

Annual Cash Flow Conversion Efficiency for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Richmond SACIF from 2006 to 2024. View RICH stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AR$65.35 Billion
≈ $47.29 Million
AR$5.62 Billion
≈ $4.07 Million
0.086x +194.63%
2023-12-31 AR$49.98 Billion
≈ $36.17 Million
AR$-4.54 Billion
≈ $-3.29 Million
-0.091x +78.32%
2022-12-31 AR$10.22 Billion
≈ $7.39 Million
AR$-4.29 Billion
≈ $-3.10 Million
-0.419x -131.00%
2021-12-31 AR$5.38 Billion
≈ $3.89 Million
AR$7.27 Billion
≈ $5.26 Million
1.353x +2622.42%
2020-12-31 AR$3.38 Billion
≈ $2.45 Million
AR$-181.33 Million
≈ $-131.21K
-0.054x -193.08%
2019-12-31 AR$2.10 Billion
≈ $1.52 Million
AR$121.02 Million
≈ $87.57K
0.058x +135.14%
2018-12-31 AR$1.11 Billion
≈ $803.87K
AR$-182.16 Million
≈ $-131.81K
-0.164x -1109.58%
2017-12-31 AR$688.05 Million
≈ $497.88K
AR$11.18 Million
≈ $8.09K
0.016x +183.82%
2016-12-31 AR$189.46 Million
≈ $137.09K
AR$-3.67 Million
≈ $-2.66K
-0.019x +92.67%
2015-12-31 AR$96.12 Million
≈ $69.55K
AR$-25.42 Million
≈ $-18.40K
-0.264x -477.45%
2011-12-31 AR$50.10 Million
≈ $36.26K
AR$3.51 Million
≈ $2.54K
0.070x -62.15%
2010-12-31 AR$44.82 Million
≈ $32.43K
AR$8.30 Million
≈ $6.00K
0.185x +694.54%
2009-12-31 AR$53.73 Million
≈ $38.88K
AR$1.25 Million
≈ $905.95
0.023x -95.41%
2007-12-31 AR$13.25 Million
≈ $9.59K
AR$6.73 Million
≈ $4.87K
0.508x -69.41%
2006-12-31 AR$7.75 Million
≈ $5.61K
AR$12.87 Million
≈ $9.31K
1.661x --

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic
Market Cap
$75.88 Million
AR$104.87 Billion ARS
Market Cap Rank
#20385 Global
#55 in Argentina
Share Price
AR$1575.00
Change (1 day)
+0.96%
52-Week Range
AR$992.50 - AR$2165.00
All Time High
AR$2165.00
About

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs … Read more